Zapanta, J. B., & Gorospe, C. (2025). Efficacy of a Single-Agent Ts1 (Tegafur, Gimeracil, and Oteracil) in Recurrent Gastric Cancer after Progression from Previous Oxaliplatin, Irinotecan, and Anti-Her2 Targeted Therapy: A Case Report. Asian Pacific Journal of Cancer Care, 10(3), 989-992. https://doi.org/10.31557/apjcc.2025.10.3.989-992